drugset / Trial / NCT04176887

Levetiracetam Versus Phenytoin in Management of Pediatric Status Epilepticus

NCT04176887

Phase 4 Unknown 60 enrolled Tanta University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study will be conducted on 60 children suffering from status epilepticus who will be admitted to Pediatric Neurology Unit and Pediatric ICU of Tanta Hospital University.

Timeline

Start
2019-01-01
Primary completion
2020-02-01
Completion
2020-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Levetiracetam Other / unclassified 20 mg/kg Intravenous
Subject Levetiracetam Other / unclassified 40 mg/kg Intravenous
Comparator Phenytoin Unknown 20 mg/kg Intravenous
Comparator Phenytoin Unknown 40 mg/kg Intravenous

Indications

No indication recorded.